Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IxCell hUC-MSC-O in knee osteoarthritis
NCT06716281Phase 3Recruiting
- Sponsor
- iXCells Biotechnologies
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of IxCell hUC-MSC-O in knee osteoarthritis (OA), sponsored by iXCells Biotechnologies. Started Jan 2024; status: recruiting.
02
Drugs
IxCell hUC-MSC-O
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06716281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06716281.